Clinical Development Stocks List
Symbol | Grade | Name | % Change | |
---|---|---|---|---|
DCPH | A | Deciphera Pharmaceuticals, Inc. | 0.00 | |
FUSN | A | Fusion Pharmaceuticals Inc. | 0.00 | |
REGN | A | Regeneron Pharmaceuticals, Inc. | 0.57 | |
GMED | B | Globus Medical, Inc. | -0.83 | |
ALNY | B | Alnylam Pharmaceuticals, Inc. | 0.13 | |
KRYS | B | Krystal Biotech, Inc. | -0.75 | |
MEDP | B | Medpace Holdings, Inc. | -1.12 | |
ICLR | B | ICON plc | 0.97 | |
SRPT | B | Sarepta Therapeutics, Inc. | -0.79 | |
DCTH | B | Delcath Systems, Inc. | -1.31 |
Related Industries: Biotechnology Diagnostics & Research Drug Manufacturers - Specialty & Generic Information Technology Services Medical Devices
Related Stock Lists:
Biotechnology
Medicine
Biopharmaceutical
Clinical Research
Antibodies
Biology
Cholesterol
Contract Research Organization
Contract Research Organizations
Infectious Diseases
Inflammation
Life Sciences
Liver Cancer
Pain
Rare Diseases
Therapeutic Gene Modulation
Tumor
Tyrosine Kinase Receptors
Acute Intermittent Porphyria
Alnylam Pharmaceuticals
Symbol | Grade | Name | Weight | |
---|---|---|---|---|
EIRL | D | iShares MSCI Ireland Capped ETF | 23.47 | |
HELX | B | Franklin Genomic Advancements ETF | 20.98 | |
BBH | B | Market Vectors Biotech ETF | 18.84 | |
IBBQ | A | Invesco Nasdaq Biotechnology ETF | 14.95 | |
IBB | B | iShares Nasdaq Biotechnology Index Fund | 14.35 |
Compare ETFs
Related Industries:
Biotechnology
Diagnostics & Research
Drug Manufacturers - Specialty & Generic
Information Technology Services
Medical Devices
Related Stock Lists:
Biotechnology
Medicine
Biopharmaceutical
Clinical Research
Antibodies
Biology
Cholesterol
Contract Research Organization
Contract Research Organizations
Infectious Diseases
Inflammation
Life Sciences
Liver Cancer
Pain
Rare Diseases
Therapeutic Gene Modulation
Tumor
Tyrosine Kinase Receptors
Acute Intermittent Porphyria
Alnylam Pharmaceuticals
- Clinical Development
Clinical development is the process of developing a new drug, medical device, or diagnostic test from the initial concept to the point of regulatory approval. It involves a series of steps, including preclinical research, clinical trials, regulatory review, and post-marketing surveillance. The goal of clinical development is to demonstrate the safety and efficacy of a product in order to obtain regulatory approval for marketing.
Popular Now
Recent Comments
- TraderMike on Bollinger Band Squeeze
- TraderMike on Bollinger Band Squeeze
- OpenCat584 on Bollinger Band Squeeze
- Dr_Duru on Expansion Breakout
- TraderMike on New Scans: Strong, Oversold Stocks and Weak, Overbought Stocks
From the Blog
Featured Articles